Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed) | PAR 19 268

Opportunity Information: Apply for PAR 19 268

The National Institutes of Health (NIH) funding opportunity titled "Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)" (Funding Opportunity Number PAR-19-268) supports the planning and delivery of an annual, intensive workshop or conference aimed specifically at early stage HIV/AIDS investigators who use nonhuman primate (NHP) models. The central purpose is to help these researchers strengthen the bridge between preclinical NHP findings and eventual human clinical trials by giving them practical, field-specific guidance on designing, interpreting, and presenting NHP studies in ways that meaningfully inform clinical development decisions.

The meeting is expected to focus on how NHP research can reduce the incidence of HIV infection and advance HIV/AIDS interventions. Priority scientific themes include HIV vaccine development and testing, the development of next-generation HIV therapies (including strategies that may contribute to cure research), and research addressing HIV-associated coinfections, comorbidities, and complications. The agenda should also cover infection prevention strategies and the broader translational pathway from animal-model results to human trial concepts, including what kinds of evidence are most persuasive and actionable when moving toward clinical evaluation.

Beyond scientific content, the FOA places strong emphasis on professional development for early stage researchers. Applicants are encouraged to design a conference that builds real-world skills in networking and collaboration, grantsmanship (such as crafting competitive NIH applications and understanding review expectations), and developing goal- and milestone-driven research plans. In other words, the event is meant to function not only as a technical training venue, but also as a career-building and community-forming platform that helps newer investigators establish sustainable, fundable research trajectories in HIV/NHP translational science.

The FOA also highlights specific methodological and contextual issues that should be addressed in conference programming. These include statistical considerations relevant to NHP research designs and inference, host genetics factors that may affect outcomes and translation, and practical methods for translating NHP findings into clinical trial strategies in humans. Another expected topic area is how to create or refine NHP research programs so that they better mirror clinical observations in people living with HIV, strengthening the relevance of animal model work to real patient populations and clinical endpoints.

This opportunity uses the NIH Research Conference Grant mechanism (R13) and is categorized under Health (CFDA 93.351). It is explicitly "Clinical Trial Not Allowed," meaning the award is intended to support the conference activity rather than the conduct of clinical trials. The original closing date listed for this announcement was 2019-09-10, and the posting creation date was 2019-05-03.

Eligibility is broad across U.S.-based organizations and includes state, county, and local governments; public and private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status); for-profit organizations (other than small businesses) and small businesses; independent school districts; public housing authorities/Indian housing authorities; and federally recognized Native American tribal governments, as well as tribal organizations that are not federally recognized. The FOA also calls out additional eligible applicant types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions.

At the same time, the announcement is clear about restrictions related to foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, and non-domestic components of U.S. organizations are not eligible. Foreign components, as defined by the NIH Grants Policy Statement, are not allowed. In practice, this means the conference project must be organized and carried out within the allowable U.S.-based institutional framework without foreign components under NIH definitions.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.351.
• This funding opportunity was created on 2019-05-03.
• Applicants must submit their applications by 2019-09-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 19 268

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: